Rho-related GTP-binding protein RhoF (RHOF) (Middle Region) Peptide
-
- Target See all RhoF (RHOF) products
- RhoF (RHOF) (Rho-related GTP-binding protein RhoF (RHOF))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-RHOF antibody (Catalog #: ARP57310_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- RhoF (RHOF) (Rho-related GTP-binding protein RhoF (RHOF))
- Background
-
RHOF is a plasma membrane-associated small GTPase which cycles between an active GTP-bound and an inactive GDP-bound state. RHOF causes the formation of thin, actin-rich surface projections called filopodia. RHOF functions cooperatively with CDC42 and Rac
Alias Symbols: ARHF, FLJ20247, RIF
Protein Size: 211 - Molecular Weight
- 23 kDa
- Gene ID
- 54509
- NCBI Accession
- NM_019034, NP_061907
- UniProt
- Q9HBH0
-